Atopic dermatitis in infancy — RACGP Fellowship MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Apply low-potency topical corticosteroid to active facial eczema for flare control
Explanation lettering: B = shown as A · C = shown as B · D = shown as C · A = shown as D
A is correct. An appropriately selected low-potency topical corticosteroid applied to active facial eczema, alongside continued generous emollient use and clear quantity instructions, is effective and safe when used correctly. B removes essential barrier therapy. C exposes an infant to systemic harms and is not routine maintenance. D uses excessive potency and duration on thin facial skin. E does not treat the underlying inflammation and is unnecessary without infection. Addressing corticosteroid phobia is part of treatment because undertreatment perpetuates inflammation, sleep disruption and secondary infection risk.
Reference: Australian Prescriber: Treatments for atopic dermatitis: https://australianprescriber.tg.org.au/articles/treatments-for-atopic-dermatitis.html